Tokyo-based Asklep joins Medidata partner programme to expand clinical trial services

Asklep has joined the Medidata Solutions Partner Programme to increase the quality and efficiency of clinical trials.

Asklep, a leading provider of clinical research services based in Tokyo, has announced its decision to join the Medidata Solutions Partner Programme.

The move is part of the company's strategy to expand its clinical trial services in the Asia Pacific region and support its sponsors more effectively.

It will use the Medidata platform to increase the quality and efficiency of its clinical trials and post-marketing studies, helping to streamline key areas of the clinical trials process for its customers.

By seeking several accreditations across Medidata's cloud-based platform, Asklep will benefit from being able to offer a variety of on-demand resources, including electronic data capture and clinical data management.
Masahito Ikeda, corporate officer and deputy division director of clinical information at the company, said: "It's critical that our partners share our mission and dedication to improving the clinical trial process for research sponsors.

"We've been impressed with Medidata's track record streamlining global trials of all sizes and phases and the strong preference among sites to use the Medidata platform for electronic patient data capture."

Tarek Sherif, chief executive officer of Medidata Solutions, added that Asklep joins a growing community of partners that use the company's cloud-based platform to improve productivity and reduce costs.